TIDMFUM

RNS Number : 7387F

Futura Medical PLC

22 May 2017

 
 For immediate release    22 May 2017

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology today announces that an application has been made to the London Stock Exchange to extend its block listings of securities in respect of a total of 3,360,000 ordinary shares of 0.2 pence each (the "Ordinary Shares") which may arise pursuant to the exercise of options under its Unapproved Share Option Scheme ("USOS") and its EMI Share Option Scheme ("EMI").

Admission of the above additional shares to be block listed is expected to occur on or around 25 May 2017.

The Company makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over Ordinary Shares.

The table below provides further detail:

 
  Name of company:                           Futura Medical plc 
  Name of scheme(s):                         USOS 
                                              EMI 
  Period of return:                          From:                   25 November 2016 
                                             To:                     22 May 2017 
 
                                               USOS:                   1,156,321 
                                             EMI:                    1,364,141 
                                                                   ----------------------------------------- 
  Number and class of securities not 
   issued under the scheme(s) at 
   beginning of period                       Total:                  2,520,462 
  Number and class of securities admitted 
   to the scheme(s) in the period            USOS:                   1,466,208 
                                             EMI:                    1,893,792 
                                                                   ----------------------------------------- 
                                             Total:                  3,360,000 
  Number of securities issued under the 
   scheme(s) during the period 
 
   Number of securities lapsed under the 
   scheme(s) during the period               USOS:                   (176,419) 
                                             EMI:                    (236,543) 
 
                                              USOS:                   - 
                                              EMI:                    - 
  Balance of securities under the 
   scheme(s) not yet issued at the end of 
   the period                                USOS:                   2,446,110 
                                             EMI:                    3,021,390 
                                                                   ----------------------------------------- 
                                             Total:                  5,467,500 
 
  Number and class of securities             USOS:                     814,424 on 25 May 2011, 1,202,280 on 8 
  originally admitted and the date of                                  October 2013, 
  admission                                                            1,466,208 on 25 May 2017 
                                             USOS Total:             3,482,912 
 
                                             EMI:                    1,520,576 on 25 May 2011, 1,467,720 on 8 
                                                                     October 2013, 
                                                                     1,893,792 on 25 May 2017 
                                             EMI Total:              4,882,088 
 
                                             Total:                  8,365,000 
  Name of contact:                           Derek Martin, Chief Financial Officer 
  Telephone number of contact:               +44 (0) 1483 685 670

For further information please contact:

 
  Futura Medical plc 
  James Barder, Chief Executive                   Tel: +44 (0) 1483 
                                                            685 670 
  Email to: james.barder@futuramedical.com    www.futuramedical.com 
   N+1 Singer (Nominated Adviser 
    and Broker) 
  Aubrey Powell / Liz Yong                      Tel:+44 (0) 20 7496 
   Corporate Finance                                           3000 
  For media enquiries please 
   contact: 
  Buchanan 
  Mark Court / Sophie Cowles                   Tel: +44 (0) 20 7466 
   / Stephanie Watson                                          5000

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

BLRPGUUWAUPMGQG

(END) Dow Jones Newswires

May 22, 2017 02:01 ET (06:01 GMT)

Futura Medical (LSE:FUM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Futura Medical Charts.
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Futura Medical Charts.